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Abstract: This study compared phenotypic and genotypic identification of Actinomyces strains, tested susceptibility to  
antibiotics and evaluated their clinical importance. Thirty-four Actinomyces strains were examined; sixteen type strains, 
and 18 clinical strains from different hospitals in Denmark from the period 2003-2005. Partial 16S rDNA sequencing  
using a stretch of 526 bases was used for genotypic identification. Susceptibility testing was done by E-test. The antibiotics 
examined were: benzylpenicillin, piperacillin with tazobactam, ceftriaxone, meropenem, erythromycin, clindamycin, line-
zolid, moxifloxacin, tetracycline and tigecycline. Clinical parameters were obtained by reviewing patient records. There 
was poor agreement between the phenotypic and genotypic identification. Phenotypic tests were helpful in identifying 
strains closely related by DNA sequences. The strains were sensitive to the examined antibiotics except for moxifloxacin 
to which most strains were resistant, and a few strains were resistant to meropenem and tetracycline. The clinical   
strains were from many different types of infections and locations. None of the patients was described as having typical 
actinomycetic lesions, and an apparently good outcome was obtained with different treatment regimens.  
Keywords: Actinomyces species, Bacterial identification, phenotypic characterization, partial 16S rDNA sequencing.  
INTRODUCTION 
 The  genus  Actinomyces consists of a heterogeneous 
group of anaerobic and facultative anaerobic, asporogenous, 
Gram-positive, non-acid-fast, rod-shaped organisms [1], 
many of which occur as inhabitants of mucosal surfaces, 
particularly the oral cavity, of humans and animals. Actino-
myces species can cause actinomycosis, a chronic granulo-
matous lesion, forming suppurative abscesses and draining 
sinuses. Localization is most often cervicofacial (60%),   
thoracic (15%) or abdominal (20%) [1]. Both laboratory 
identification and clinical diagnosis is often troublesome. 
Coryneform bacteria are difficult to classify at the species or 
even at the genus level [2] and poses major problems for 
clinical microbiology laboratories in terms of labour, time, 
and cost, when conventional methods are used. Panels of 
phenotypic characteristics useful in identifying species have 
been described by Funke et al. [2] and Sarkonen et al. [3]. 
  An increased recognition of the importance of coryne-
form bacteria as opportunistic human pathogens within the 
last decade [4], has occurred in a period where new diagnos-
tic tools for identification of bacteria progressively have 
been introduced. These techniques, especially sequencing of 
genes coding for rRNA have revolutionized the insight into 
phylogeny and taxonomy of bacteria.  
  We therefore found it relevant to characterize 34 strains 
of  Actinomyces species from humans, 18 recent Danish   
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clinical strains and 16 type strains of different species, using 
a recent phenotypical identification scheme, and compare   
the results to genotypic identification using partial 16S 
rDNA sequencing. In addition, susceptibility to antibiotics 
was determined and data on clinical manifestations of the 
respective patients was obtained. 
MATERIALS AND METHODS 
Bacterial Strains  
 We  examined  34  Actinomyces strains. Sixteen type 
strains, received from CCUG (Culture Collection, University 
of Göteborg, Göteborg, Sweden), were included: A.  
europaeus  CCUG 32789A
T,  A. funkei CCUG 42773
T,  A. 
georgiae CCUG 32935
T, A. gerencseriae CCUG 32936
T, A. 
graevenitzii CCUG 27294
T,  A. israelii CCUG 18307
T,  A. 
meyeri CCUG 21024
T, A. naeslundii CCUG 18310
T, A. neuii 
subsp. neuii CCUG 32252
T, A. neuii subsp. anitratus CCUG 
32253
T,  A. odontolyticus CCUG 20536
T,  A. radicidentis 
CCUG 36733
T,  A. radingae CCUG 32394
T,  A. turicensis 
CCUG 34269
T, A. urogenitalis CCUG 38702
T, A. viscosus 
CCUG 14476
T. Eighteen strains were clinical strains submit-
ted from Danish Departments of Clinical Microbiology   
to the National Reference Laboratory for identification   
of bacteria, at Statens Serum Institut (SSI), in the period   
February 2003 - March 2005. All strains were kept as frozen  
(- 80 °C) stocks. 
Phenotypic Identification 
  The strains were subcultured on 10 % horse blood agar 
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were incubated for five days at 35 °C in ambient air, a CO2-
enriched (5 %) and an anaerobic atmosphere, respectively. 
Colonial morphology and microscopic appearance in Gram-
stained preparations were noted. CAMP reaction was   
examined on CAMP agar (SSI Diagnostica) with a beta-
hemolysin-producing strain of Staphylococcus aureus. 
CAMP-plates were incubated at 35 °C in a CO2-enriched (5 
%) and an anaerobic atmosphere, respectively, and were read 
after 24-h and 48-h incubation. Testing for nitrate reduction 
was performed using a nitrate broth culture (semi-solid agar) 
incubated at 35 °C in an anaerobic atmosphere for a   
minimum of five days, prior to addition of sulfanilic acid, 
Cleves acid, and if necessary zinc powder [5, 6]. Rosco   
diagnostic tablets (Rosco A/S, Taastrup, Denmark) were 
used for testing hydrolysis of urea and esculin, production of  
-fucosidase,  -glucosidase,  -N-acetylglucosaminidase  
(-NAG) and -galactosidase (ONPG), and acid production 
from L-arabinose, following the instructions of the manufac-
turer.  A. israelii and A. gerencseriae were differentiated 
from each other by the presence of -mannosidase and   
arginine dihydrolase (ADH). Acid production from L-
arabinose, maltose, mannitol, raffinose, rhamnose, sucrose, 
xylose and trehalose was tested in tubes with extract-
bouillon and the carbohydrate (SSI Diagnostica) [6], incu-
bated at 35 °C in an anaerobic atmosphere for a minimum of 
five days. Horse citrate plasma was added to promote 
growth. All tests, except testing for the presence of -
mannosidase, were performed by more than one method, as 
the strains were also tested with the API strips, Rapid ID 
32 A and API
  20 A (bioMérieux
 as, Marcy l’Etoile, 
France) following the instructions of the manufacturer. 
Rapid ID 32 A tested: ability to reduce nitrate, the presence 
of urease, -fucosidase, -glucosidase, -NAG, ONPG and 
ADH, and acid production from raffinose. API  20 A 
tested: presence of urease, hydrolysis of esculin, acid   
production from arabinose, maltose, mannitol, raffinose, 
rhamnose, sucrose, xylose and trehalose. Catalase was   
detected with 10 % H2O2 in a well in the API 20 A strip 
with a positive reaction. 
Ribosomal DNA Sequencing 
  For molecular biological study DNA was released by 
heating isolated bacteria at 95°C for 5 min. PCR amplifica-
tion of part of the 16S rRNA gene was performed using   
the primers BSF-8 and BSR-534 as previously described [7]. 
DNA sequences were aligned and edited at http://bioinfo. 
genotoul.fr/multalin/multalin.html resulting in comparable 
sequences ranging from 324 to 351 basepairs. Furthermore, 
all edited sequences were compared to deposited sequences 
in the Bio Informatic Bacteria Identification database.   
Sequences obtained for clinical strains were compared to 
original CCUG sequences of collection strains. Results were 
illustrated in a phylogentic tree using CLC workbench 4.5 
software.  
Susceptibility Testing  
  The MICs of all the strains were determined using E-test 
(AB Biodisk, Solna, Sweden) for the following antibiotics: 
benzylpenicillin, piperacillin with tazobactam, ceftriaxone, 
meropenem, erythromycin, clindamycin, linezolid, moxi-
floxacin, tetracycline, and tigecycline. All tests were per-
formed on anaerobic plates (SSI Diagnostica). Plates were 
inoculated with the bacterial isolates in API suspension   
medium (demineralised water) (bioMérieux
 as, Marcy 
l’Etoile, France) with a turbidity equivalent of McFarland 
standard 4,0 [8] and incubated anaerobically at 35 ºC for 48-
72 hours. Results were read according to the manufacturer’s 
guidelines. Quality controls were performed using Bacteroi-
des fragilis (ATCC 25285). MIC measurements (at least 
triplicate) for the control strain were as follows: Penicillin:  
> 32 μg/ml, piperacillin/tazobactam: 0.25-0.5 μg/ml, cef-
triaxone: 32 μg/ml, meropenem: 0.064 μg/ml, erythromycin: 
1.5 μg/ml, clindamycin: 0.75-2.0 μg/ml, linezolid: 1.5 μg/ml.  
Clinical Data 
  Information on predisposing factors, actual diagnosis and 
antibiotic treatment was recorded from patient files. 
RESULTS 
Phenotypic Identification 
  The appearance of the strains varied both in the Gram-
stained preparations and with growth on agar. Micro- 
scopically many strains were without visible branching, 
many were small rods with an appearance similar to the 
coryneforms, other were coccoid or long and curved rods. 
On agar most strains were grey or white, colony-sizes ranged 
from pinpoint to three mm in diameter, and some had -
haemolysis. Colonies could be rough or smooth, elevated or 
flat, and some adhered to agar. The incubation atmosphere 
influenced appearance and growth; some strains did not 
grow in ambient air.  
 Table  1 shows results of phenotypic identification of 
Actinomyces strains following the recommendations of   
Sarkonen et al. [3]. All type strains were correctly identified. 
We used the same type strains as Sarkonen et al. except for 
the type strain of A. israelii. The clinical strains were 
grouped from the phenotypic identification; one strain could 
not be designated to a species by the performed phenotypic 
characterization. 
  Results of individual biochemical reactions sometimes 
differed when tested with different methods. This was for 
example seen when testing nitrate reduction, esculin   
hydrolysis and acid production from carbohydrates.  
Genotypic Identification 
  All type strains were correctly identified. For the 16 type 
strains best taxon match had scores from 642 to 672 bits and 
differences to next best taxon matches between 22 and 260 
bits. Some species were more closely related than others;   
A. meyerii and A. odontolyticus were most closely related, 
followed by A. viscosus and A. naeslundii. A. radingae was 
least connected to the other species. For 18 clinical strains 
scores of 480 to 670 bits were found with differences to next 
best taxon matches between 2 and 245 bits.  
  One of the clinical strains could not be allocated to a   
species on phenotypic characteristics, wherefore 17 clinical 
strains could be compared (Fig. 1). Actinomyces species: A Danish Survey  The Open Microbiology Journal, 2009, Volume 3    115 
Table 1.   Results from Phenotypic Identification of Strains of Actinomyces
a 
Hydrolysis of:  Production of:  Fermentation of: 
Species and 
Strain(s) 
Pigment  Catalase 
Nitrate 
Reduction 
CAMP 
Test 
Urea Esculin 
-Fuco- 
sidase 
-Gluco- 
sidase 
- 
NAG 
-Galac- 
tosidase 
Arab- 
inose 
Mal- 
tose 
Man- 
nitol 
Raffi- 
nose 
Rham- 
nose 
Suc- 
rose 
Xy- 
lose 
Tre- 
halose 
A. europaeus 
CCUG 32789 A
T  
   +    +   +   +  +      v    
A. funkei  
CCUG 42773
T  
   +      +  +   v v  v     + + +  
A. georgiae  
CCUG 32935
T  
   v    v   +   +  +  v + + + + 
A. gerencseriae  
CCUG 32936
T, 1 
clinical strain 
   v,       +  , +  +   +  ,  v + v,  +  , +   + + + 
A. graevenitzii 
 CCUG 27294
T                +  +  +   +  v  +    
A. israelii  
CCUG 18307
T, 2 
clinical strains 
   +,  v    +   +    +  v + v +  v,   +  +  + 
A. meyeri CCUG 
21024
T  
             +   +  +  v  + + v 
A. naeslundii 
CCUG 18310
T  
   +    +   +   +  +  +  +  + 
A. neuii subsp. 
Neuii 
CCUG 32252
T, 2 
clinical strains 
 +  +,  v  +       +   +  + + v  + +  +,  v 
A. neuii subsp. 
anitratus  
CCUG 32253
T  
 +   +   +   +   +  + + +  + + + 
A. odontolyticus 
CCUG 20536
T, 2 
clinical strains 
, +   +     , v  +, v  +   +  +   v +,  v +  +   
A. radicidentis 
CCUG 36733
T  
 +  v    v   +   +  + + +  +  + 
A. radingae  
CCUG 32394
T, 2 
clinical strains 
    , v     v,  +  +  + v,     +  +, v  +   v  +, v    +  +, v  +, v 
A. turicensis 
CCUG 34269
T, 5 
clinical strains 
           +,  v  +    , v  , v  v, +       + +  
A. urogenitalis 
CCUG 38702
T  
   +    +   +  +  +  v  +   + + + + + 
A. viscosus  
CCUG 14476
T, 3 
clinical strains 
 +  , v       v   +   +  , v  +   +  +  , v  v 
A. species     +        +   + v  +   v  + +  
a , negative result; +, positive result; v, variable reaction (by different methods or among strains). Results for type strains are given first if different from the results obtained on 
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Fig. (1). Phylogenetic tree illustrating the relationship between the 16 type strains and the 18 clinical strains. Six clinical strains did not reach 
concordance between genotypic / phenotypic* identification (five with different species names and one with no species identification). The 
remaining 12 strains were allocated to the same species when comparing the two methods of identification.  
Genotypic/Phenotypic Identification 
  Ten of the 17 clinical strains showed methodological 
agreement at the species level. Two additional strains 
showed concordance as BLAST examinations could not 
separate (bits score difference < 30) between A. viscosus and 
A. naeslundii; the latter was proposed from phenotypic char-
acterization (and second BLAST choice) and the former 
from first BLAST choice. Thus, for 12 of 17 strains results 
from phenotypic and molecular examinations were in agree-
ment. BLAST examinations for all strains seemed very con-
vincing when taking all parameters into consideration (Fig. 
1). Thus, for five of 17 clinical strains identifications by 
genotypic/phenotypic methods were in disagreement as indi-
cated in Fig. (1) with an *. One isolate could not be desig-
nated to a species based on phenotypic characterization, 
which by genotypic identification belonged to the species A. 
meyerii. The isolates with disagreeing identifications were 
(genotypic/phenotypic identification): 1) A. odontolyticus/A. 
radingae (n=1), 2) A. radingae/A. gerencseriae (n=1), 3) A. 
gerencseriae/A. israelii (n=1), 4) A. israelii/A. viscosus and 
5) A. meyerii/A. turicensis.  
Susceptibility Testing  
  The MICs for the 34 strains are shown in Table 2. All 
strains were sensitive to benzylpenicillin, piperacillin/ 
tazobactam, ceftriaxone, meropenem, erythromycin, clin-
damycin, linezolid, tetracycline and tigecycline, except for 
meropenem and tetracycline where one strain for each anti-
biotic had MIC values above the upper limits for sensitivity. 
Notably for moxifloxacin, 21 strains had MIC`s above the 
upper limit for being sensitive though most strains (n=16) 
were close to the breaking point. We experienced difficulties 
reading zone diameters due to hazy zone edges, which   
explains why it was not possible to define an MIC value for 
1-5 strains for each antibiotic.  
Clinical Data 
 Table  3 shows clinical and microbiological data on the 18 
patients from whom Actinomyces species were isolated. The 
patients have been divided into groups based on species   
designations from the genotypic identification. The clinical 
strains were chosen at random during the period February 
2003 - March 2005. The median age was 54 years, 10 were 
men and 8 women. 
  The strains were from soft tissue infections (5 strains), 
blood (4), intraabdominal abscesses (3), periodontal infec-
tions (2), and one strain each from pus from bladder,   
empyema of the pleural space, spinal fluid and a swab from 
cornea. Actinomyces species: A Danish Survey  The Open Microbiology Journal, 2009, Volume 3    117 
  Nine patients received both surgical intervention and 
antibiotic treatment and, respectively, 5 and 4 patients   
received either antibiotic treatment or surgical intervention. 
When antibiotics were given, the drug(s) and duration   
varied, but always included -lactam antibiotics. The follow-
ing  -lactam antibiotics were used: penicillin, ampicillin, 
dicloxacillin, mecillinam, cefuroxime, ceftriaxone and   
meropenem. In some cases ciprofloxacin, gentamicin and 
metronidazole were added. The patient with keratitis was 
treated with topical agents containing chloramphenicol,   
tetracycline, polymyxin and gentamicin. All patients recov-
ered, except one who died from other causes. Two patients 
had sequelae; one each with neurologic sequelae following 
meningitis and reduced vision following keratitis. 
DISCUSSION 
  When describing the species A. europaeus in 1997 [2], 
Funke et al. used 15 phenotypic characteristics to differenti-
ate the species from other human-derived, aerobically grow-
ing  Actinomyces and Arcanobacterium  species. In the 
scheme by Sarkonen et al. [3] using 18 characteristics, which 
also is used in this study, the same characteristics were used 
except that pyrazinamidase production and acid production 
from glucose plus glycogen was not tested for. However, 
additionally the scheme by Sarkonen et al. [3] takes into 
consideration pigmentation, production of -fucosidase and 
acid production from arabinose, raffinose, rhamnose and 
trehalose. The number of Actinomyces species has increased 
since these schemes were made. Often new species have 
been created from subgroups of existing species, complicat-
ing the destinction between species based on phenotypic 
characteristics as inclusion of new tests have been needed  
for differentiation between species [1]. The fact that the   
 
same reaction done with different methods, as also seen in 
this study, may result in diverse results complicates pheno-
typic identification even more. Recently, former genospecies 
1 and 2 of A. naeslundii have been validly published as   
A. oris sp. nov. and A. johnsonii sp. nov.; these new species 
cannot be readily differentiated using conventional pheno-
typic testing [9]. All these developments stresses the need  
for applicating molecular methods for identification of 
Actinomyces. 
 Actinomyces  species has a varied appearance in the   
microscope. It may be the typical Gram-positive branching 
bacilli, which often present with a beaded appearance,   
but not seldom more coccoid or variable forms occurs. Like-
wise, the typical molar tooth appearance of A. israelii may 
be absent. The appearance may be similar to common 
relatively avirulent pathogens, which often may be present 
together with Actinomyces species. It is therefore likely   
that  Actinomyces  sometimes is overlooked in samples.   
Misidentifications or non-identifications are presumed to 
occur in the routine microbiology laboratory. 16S rRNA 
gene sequence analysis has shown to be a powerful test   
in confirming or identifying suspected or non-identified 
Actinomyces species.  
  Three of the examined strains had very low differences  
in scores between best and next best taxon matches. When 
examining phylogenetic trees based on a comparison of   
approximately 1,320 nucleotides, A. meyerii and A. odon- 
tolyticus, and A. viscosus and A. naeslundii, are closely   
related explaining the low bits-differences [2]. Results of 
phenotypic reaction may be helpful in species identification 
in such cases. All in all, 16S rDNA sequencing of a 526 base-
pair stretch gave a good separation into proposed species. 
Table  2.  Minimal Inhibitory Concentrations of 10 Antimicrobial Agents Against Actinomyces species. (n=34), Including Type 
Strains of 16 Different Species 
MIC (mg/L)  **  Antimicrobial Agent 
0.004 0.008 0.016 0.032 0.064  0.125  0.25  0.5  1  2  8  16  32   
MIC Range  
(mg/L) 
Benzylpenicillin
# 2*  1    1  9  6  6  4        5 0,004-0,5 
Piperacillin/tazobactam
#      1 1 2  2 7  7  4  7      3
  <0,016-2 
Ceftriaxone      1 1 2  6 8  5  6      4
  0,016-32 
Meropenem      5 5 4  8 5  2        1  4
  0,012-32 
Erythromycin
#     21  8    1          4
  <0,016-0,094 
Clindamycin
#      4  13  3  5  4  1  1      3
  0,016-1,5 
Linezolid       2  9  18  1      4
  0,125-0,75 
Moxifloxacin       1  3  8 10 6 4    1  1
  0,064-32 
Tetracycline
#       1  11  11  5  1  1  4
  0,094-16 
Tigecycline     1  10  12  8          3
  0,016-0,125 
1)* Number of strains with adequate growth for reading MIC 
2)** Number of strains with undefined MIC due to poor growth. 
3) Grey shadings mark the upper limit for sensitivity according to international guidelines. Values above indicates resistance. (Pharmacological breakpoints 2007 from SRGA are 
used for antibiotics marked
#. Pk/pd breakpoints from EUCAST are used for the other antibiotics). 118    The Open Microbiology Journal, 2009, Volume 3  Hansen et al. 
Table 3.  Clinical and Microbiological Data on 18 Patients from whom Actinomyces species were Isolated 
Species/ no. of 
Isolates 
Age 
Land Sex 
Isolated from  Underlying Illness  Major Clinical  
Manifestations 
Coisolates Treatment  Outcome 
A. odontolyticus/ 1  56 F  blood   cirrhosis  bloody vomiting 
and diarrhoea 
-
a  antibiotics (m, mt)  death from other 
causes 
A. turicensis/ 4  24 F  pus (nates)  -
a  soft tissue abscess  
on nates 
- surgery  recovery 
  56 M  tissue (necrotic)  extraction of  
infected tooth 
fasciitis of face and 
neck  
H. parainfluenzae, NHS, 
CNS, Prevotella spp. 
surgery, 17 and  
later 15 days of  
antibiotics (p/cu + mt, d) 
recovery 
  63 F  pus (bladder)  chronic dialysis  cystitis  B. fragilis, CNS  rinsing of the bladder,  
25 days of antibiotics  
(d, ci + mt) 
recovery 
  46 F  pus (rectum)  -  rectum abscess  -  drainage, 6 weeks of 
antibiotics (p, g, mt, 
followed by p alone)  
recovery 
A. neuii/ 2 91  M  blood  chronic  
nephropathy 
cystitis -  9 days of antibiotics  
(cu, mc) 
recovery 
 67  M  blood  surgery of  
ureter-stenosis 
perirenal abscess  CNS, coryneforms  drainage, min. 37 days  
of antibiotics  
(a, followed by p + ci) 
recovery 
A. meyeri/ 4  34 M  pus (cheek)  extraction of  
infected tooth 
soft tissue abscess  
on cheek 
-  surgery and  
antibiotics (d) 
*does not show for  
check-up 
  33 M  root of a tooth  -  periodontal  
infection 
throat-flora  dental treatment and 
antibiotics (p) 
recovery 
  36 M  pus (pleura)  cerebral palsy, 
epilepsy 
empyema following  
episode of  
pneumonia 
microscopy also showed 
Gram-pos. cocci in chains 
drainage, decorticatio,  
2-3 weeks of antibiotics 
(cu, mt) 
*does not show for  
check-up 
  66 M  pus (abdomen)  long episode of  
intermittent  
diarrhoea 
periappendical  
abscess 
E. coli  drainage (twice)  recovery 
38 M  spinal fluid  alcoholism  meningitis  -  antibiotics (initially high 
doses of p, a, ct) 
neurologic  
sequelae 
A. israelii/ 2 
35 F  pus (abdomen)  -  periappendical  
abscess 
-  surgery, 4 days of  
antibiotics (cu, mt) 
recovery 
A. radingae/ 2  52 M  pus (scrotum)  -  soft tissue abscess  
of scrotum 
anaerobic Gram-pos.  
cocci and Gram-neg. rods 
surgery, a prior to  
hospitalization 
recovery 
  74 F  pus (back)  -  soft tissue abscess  
on the back 
- surgery  recovery 
A. viscosus/ 1  87 F  blood  COLD, Mb. cordis  source unknown  -  9 days of antibiotics  
(cu, p, mc) 
recovery 
A. naeslundii/ 1  52 F  swab (cornea)  treated thyroid  
disease 
keratitis followed  
injury of the cornea 
Lactobacillus sp. found 
in other samples 
topical antibiotics   reduced vision 
A. gerencseriae/ 1  66 M  swab (oral cavity)  -  periodontal  
infection 
-  surgery, 4 weeks of  
antibiotics (p) 
recovery 
F, female, M, male, 
a-, none, 
*, assumed recovery 
H., Hæmophilus, B., Bacteroides, NHS, non-hemolytic streptococci, CNS, coagulase-negative staphylococci, pos., positive, neg., negative  
a, ampicillin/amoxicillin, ci, ciprofloxacin, ct, ceftriaxone, cu, cefuroxime, d, dicloxacillin, g, gentamicin, m, meropenem, mc, mecillinam, mt, metronidazole, p, penicillin. 
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Sequence analysis is especially useful when a rapid identifi-
cation is desired due to for example clinical circumstances. 
Thus, molecular bacterial identification is a powerful tool   
for national reference laboratories enhancing both the speed 
and validity of performed examinations. Using BLAST   
examinations may also be helpful in giving up to date   
taxonomic considerations.  
  In vitro antimicrobial susceptibility of Actinomyces  
species is quite predictable [10]. Strains are generally sensi-
tive to -lactams. However, some may exhibit higher MIC 
values as also shown by McNeil and Schaal. The medium we 
used for susceptibility testing contains L-cystein, which   
reduces the activity of -lactam antibiotics [11]; therefore, 
underestimated susceptibility for these antimicrobial agents 
can be expected. Erythromycin was the most active antimi-
crobial agent in vitro, followed by tigecycline. Clindamycin, 
linezolid and tetracycline also showed good in-vitro activity 
with MICs within the therapeutic range for all strains, except 
one strain, that was resistant to tetracycline. It is important 
knowing that fluorquinolones generally have poor activity 
against  Actinomyces species [10]. In agreement with this 
moxifloxacin for most strains in this study had MIC values 
above the upper limit for sensitivity. Susceptibility testing  
of  Actinomyces species can be problematic; therefore, it 
would be relevant to elaborate standard guidelines for   
susceptibility testing procedure and to determine species-
specific breakpoints. 
  In the article by Clarridge III and Zhang [12] a large 
number of clinical Actinomyces species were examined. Sev-
enty-three strains were identified by genotypic identification. 
A. turicensis was the most frequently isolated species. With 
genotypic identification the most frequently identified   
species in our study were A. turicensis and A. meyeri. The 
normal niche of A. turicensis has been assessed [12] to be 
gastrointestinal, genital or skin in that area. Some strains 
were also isolated from abscesses of the face, neck, breast, 
chest and back. Our findings are in accordance with this, see 
Table 3. The normal niche of A. meyeri, A. israelii and A. 
odontolyticus was assessed to be oropharynx, and this is in 
accordance with three of our A. meyeri strains being from 
abscess of cheek, root of tooth and empyema of pleural 
space, respectively. Finally, A. radingae was associated with 
chronic soft tissue abscesses of the breast, chest and back, 
and the normal niche was assessed to be skin of the upper 
body. One of our two strains was from an abscess on the 
back.  
 Actinomyces is often difficult to diagnose and eradicate, 
needing surgery and a long course of antibiotics [13, 14]. 
Typical actinomycetic lesions contain between 1 and 10 bac-
terial species in addition to the pathogenic Actinomycetes 
[10]. We do not have information of typical actinomycotic 
lesions in our patients. Several of the patients did not receive 
antibiotics at all or only short courses of treatment with   
recovery. These cases were especially soft tissue infections, 
but also abscesses in the abdomen and positive blood   
cultures. Thus, it is important to be aware of that many infec-
tions involving Actinomyces species may not present as typi-
cal actinomycetic lesions. The great recovery rate may be 
associated to the wide range of antibiotic sensitivity (except 
quinolones) among Actinomyces species and that infections 
may have a milder/different course than the classic severe  
A. israelii infections and therefore not necessitating the   
very long periods of high doses of forenstance penicillin as 
otherwise recommended.  
  In conclusion, we find poor agreement between the   
phenotypic and genotypic identification of Actinomyces  
species. Phenotypic tests were helpful in identifying strains 
closely related by DNA sequences. The examined Actinomy-
ces strains were in-vitro sensitive to many antibiotics includ-
ing ß-lactams, but not quinolones, and two strains were resis-
tant to meropenem and tetracycline, respectively. Standard 
guidelines for susceptibility testing of Actinomyces are   
lacking. With a varied appearance, both microscopically   
and on agar, often looking like common relatively avirulent 
bacteria, Actinomyces may easily be overlooked in samples. 
Actinomyces can be present in infections without typical 
actinomycetic lesions, and some of these infections probably 
do not need the same aggressive and long treatment as 
actinomycosis.  
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